AI drug discovery
2 stories
-
techIsomorphic Labs Raises $2.1B for AI Drug Discovery Platform
Backed by Alphabet and sovereign wealth funds, the company advances AlphaFold-based drug design toward clinical trials.
-
healthEli Lilly Partners with Insilico for AI Drug Discovery
Lilly and Insilico extend collaboration for AI-driven drug development, with potential deal value up to $2.75 billion.